Legal entity
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.5 for that window.
Last mentioned: Mar 25, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 1 tracked stories. Of the tracked stories, 1 of 1 also mention FDA, the most common co-covered peer. Their average consequence score of 5 runs below the beat's 6.5 for that window. Each story carries 3 original sources on average, compared with 2.9 for the broader beat in this window. PhRMA appears in 1 tracked Legal story from March 9, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 39 Legal stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering PhRMA. Shared-story counts are live from our verified record — not editorial picks.
The debate over Direct-to-Consumer (DTC) pharmaceutical advertising is intensifying as U.S. regulators face mounting pressure to align with global standards. With the U.S. remaining one of only two nations allowing the practice, new legal and ethical challenges are questioning the impact of multi-billion dollar marketing budgets on drug pricing and patient safety.
Source: willitsnews.com · pressdemocrat.com
PhRMA is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
